Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva M M Strijbis

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Neurology|June 8, 2023
Association of Arachidonic Acid-Derived Lipid Mediators With Disease Severity in Patients With Relapsing and Progressive Multiple SclerosisJelle Y Broos, Floor C Loonstra, Lodewijk R J de Ruiter, et al.
Multiple Sclerosis and Related Disorders|July 17, 2024
Clinical risk stratification: Development and validation of the DAAE score, a tool for estimating patient risk of transition to secondary progressive multiple sclerosisTom A Fuchs, Robert Zivadinov, Tetyana Pryshchepova, et al.
Frontiers in Neurology|December 12, 2025
Optimization of cervical cord atrophy measurement using a real-world, multicentre dataset in multiple sclerosisCarsten Lukas, Barbara Bellenberg, Ferran Prados, et al.
Journal of Neurology|June 24, 2025
A multi-domain lifestyle intervention in multiple sclerosis: a longitudinal observational studyIlse M Nauta, Keeva N M Loughlin, Arianne S Gravesteijn, et al.
European Radiology|April 16, 2025
User requirements for quantitative radiological reports in multiple sclerosisDavid R van Nederpelt, Zoe C Mendelsohn, Lonneke Bos, et al.
Journal of Neurology|May 7, 2026
The practice effect of smartphone-derived cognitive processing speed assessments as a proxy of cognitive functioning in multiple sclerosisDaan J de Jong, Pam C G Molenaar, Vera Verhoef, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 4, 2026
Brain atrophy rates vary with age in relapsing-remitting multiple sclerosisSezgi Kaçar, David R van Nederpelt, Julia R Jelgerhuis, et al.
Multiple Sclerosis and Related Disorders|October 24, 2024
9-HODE associates with thalamic atrophy and predicts white matter damage in multiple sclerosisWing Hee Fung, Marike R van Lingen, Jelle Y Broos, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 13, 2023
Decrease of natalizumab drug levels after switching from intravenous to subcutaneous administration in patients with multiple sclerosisAlyssa A Toorop, Zoé L E van Kempen, Maurice Steenhuis, et al.
Annals of Neurology|October 17, 2022
Ocrelizumab Concentration Is a Good Predictor of SARS-CoV-2 Vaccination Response in Patients with Multiple SclerosisZoé L E van Kempen, Laura Hogenboom, Alyssa A Toorop, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Neurology|June 8, 2023
Association of Arachidonic Acid-Derived Lipid Mediators With Disease Severity in Patients With Relapsing and Progressive Multiple SclerosisJelle Y Broos, Floor C Loonstra, Lodewijk R J de Ruiter, et al.
Multiple Sclerosis and Related Disorders|July 17, 2024
Clinical risk stratification: Development and validation of the DAAE score, a tool for estimating patient risk of transition to secondary progressive multiple sclerosisTom A Fuchs, Robert Zivadinov, Tetyana Pryshchepova, et al.
Frontiers in Neurology|December 12, 2025
Optimization of cervical cord atrophy measurement using a real-world, multicentre dataset in multiple sclerosisCarsten Lukas, Barbara Bellenberg, Ferran Prados, et al.
Journal of Neurology|June 24, 2025
A multi-domain lifestyle intervention in multiple sclerosis: a longitudinal observational studyIlse M Nauta, Keeva N M Loughlin, Arianne S Gravesteijn, et al.
European Radiology|April 16, 2025
User requirements for quantitative radiological reports in multiple sclerosisDavid R van Nederpelt, Zoe C Mendelsohn, Lonneke Bos, et al.
Journal of Neurology|May 7, 2026
The practice effect of smartphone-derived cognitive processing speed assessments as a proxy of cognitive functioning in multiple sclerosisDaan J de Jong, Pam C G Molenaar, Vera Verhoef, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 4, 2026
Brain atrophy rates vary with age in relapsing-remitting multiple sclerosisSezgi Kaçar, David R van Nederpelt, Julia R Jelgerhuis, et al.
Multiple Sclerosis and Related Disorders|October 24, 2024
9-HODE associates with thalamic atrophy and predicts white matter damage in multiple sclerosisWing Hee Fung, Marike R van Lingen, Jelle Y Broos, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 13, 2023
Decrease of natalizumab drug levels after switching from intravenous to subcutaneous administration in patients with multiple sclerosisAlyssa A Toorop, Zoé L E van Kempen, Maurice Steenhuis, et al.
Annals of Neurology|October 17, 2022
Ocrelizumab Concentration Is a Good Predictor of SARS-CoV-2 Vaccination Response in Patients with Multiple SclerosisZoé L E van Kempen, Laura Hogenboom, Alyssa A Toorop, et al.
Pageof 6